Caribou Biosciences (CRBU) EPS (Weighted Average and Diluted): 2021-2025
Historic EPS (Weighted Average and Diluted) for Caribou Biosciences (CRBU) over the last 5 years, with Sep 2025 value amounting to -$0.30.
- Caribou Biosciences' EPS (Weighted Average and Diluted) rose 21.05% to -$0.30 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.70, marking a year-over-year decrease of 2.41%. This contributed to the annual value of -$1.65 for FY2024, which is 19.57% down from last year.
- As of Q3 2025, Caribou Biosciences' EPS (Weighted Average and Diluted) stood at -$0.30, which was up 48.28% from -$0.58 recorded in Q2 2025.
- Over the past 5 years, Caribou Biosciences' EPS (Weighted Average and Diluted) peaked at $0.09 during Q4 2021, and registered a low of -$1.39 during Q2 2021.
- For the 3-year period, Caribou Biosciences' EPS (Weighted Average and Diluted) averaged around -$0.40, with its median value being -$0.42 (2024).
- As far as peak fluctuations go, Caribou Biosciences' EPS (Weighted Average and Diluted) slumped by 600.00% in 2022, and later spiked by 72.73% in 2023.
- Over the past 5 years, Caribou Biosciences' EPS (Weighted Average and Diluted) (Quarterly) stood at $0.09 in 2021, then slumped by 600.00% to -$0.45 in 2022, then grew by 11.11% to -$0.40 in 2023, then grew by 2.50% to -$0.39 in 2024, then grew by 21.05% to -$0.30 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.30 for Q3 2025, versus -$0.58 for Q2 2025 and -$0.43 for Q1 2025.